The Company
ClearCut Medical was established to develop and commercialize its proprietary technology and tools for accurate and effective removal of cancer.
ClearCut’s platform technology is based on an innovative new form factor Magnetic Resonance (MRI) that enables real-time accurate and rapid margin assessment of excised tissue in the operating room.
The company’s first product, the ClearCoast™ MRI System provides intraoperative margin assessment of surgically removed breast cancer tumors. By providing accurate, real-time and simple margin analysis to the surgeon in the OR, the system is able to significantly improve surgical outcomes and reduce re-excision rates.
To date over 400 patients have participated in international, multi-center clinical trials, which have shown excellent accuracy compared to the gold standard final histopathology and the potential to reduce the re-excision rates in breast conserving surgery by 80%.
Future applications include other surgical excisions of cancerous tumors and biopsies throughout the body.
Known & Trusted
No imaging modality is more familiar with and trusted by cancer physicians than magnetic resonance
Accuracy
450+ patients, three studies in US, Europe and Israel, high accuracy compared to microscopic pathology
IMPACT
Dramatically reduce the need for repeat cancer surgery will relieve patients, help surgeons and save billions
Team
Hezi Himelfarb
CEO
Eyal Kolka
Founder & Executive Director
Eyal, a serial entrepreneur, has devoted the last twenty years to building medical device start-up companies. He started his career as a physicist for the Israeli Defense Forces. He then went into investment banking joining Sigma P.C.M. Capital Markets as a partner. There he played a lead role in developing its assets management and investment banking activities. In 1999 Eyal joined Erez Golan and together they found TopSpin Medical. Eyal served as CFO and Senior VP of Business Development. TopSpin developed a revolutionary miniaturized MRI catheter for diagnosing coronary plaque composition. The company successfully completed clinical trials in the US and Europe, commercialized the product and went public on the Tel-Aviv Stock Exchange in 2005. In 2008 and 2010 Eyal co-founded two new companies with Erez Golan; Pi-Cardia developing non-implant based therapy for aortic stenosis and Clear-Cut.
Eyal holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem and an MBA from the Tel Aviv University
Erez Golan
Co-Founder & Executive Director
Erez, a serial entrepreneur, devoted the last twenty years to building medical device start-up companies. Earlier in his career he built a strong technology background while leading inter-disciplinary projects for the Israel Air Force. He then went into medical imaging working on novel tissue characterization algorithms for intravascular ultrasound at Medinol. In 1999 Erez founded TopSpin Medical together with Eyal Kolka, which he then led as CEO for eight years. TopSpin developed a revolutionary miniaturized MRI catheter for diagnosing coronary plaque composition. The company successfully completed clinical trials in the US and Europe, commercialized the product and went public on the Tel-Aviv Stock Exchange in 2005. In 2008-2010 Erez co-founded two new companies with Eyal Kolka: Pi-Cardia developing non-implant based therapy for aortic stenosis and Clear-Cut.
Erez holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem.
Hezi Himelfarb
CEO
Eyal Kolka
Founder & Executive Director
Eyal, a serial entrepreneur, has devoted the last twenty years to building medical device start-up companies. He started his career as a physicist for the Israeli Defense Forces. He then went into investment banking joining Sigma P.C.M. Capital Markets as a partner. There he played a lead role in developing its assets management and investment banking activities. In 1999 Eyal joined Erez Golan and together they found TopSpin Medical. Eyal served as CFO and Senior VP of Business Development. TopSpin developed a revolutionary miniaturized MRI catheter for diagnosing coronary plaque composition. The company successfully completed clinical trials in the US and Europe, commercialized the product and went public on the Tel-Aviv Stock Exchange in 2005. In 2008 and 2010 Eyal co-founded two new companies with Erez Golan; Pi-Cardia developing non-implant based therapy for aortic stenosis and Clear-Cut.
Eyal holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem and an MBA from the Tel Aviv University
Erez Golan
Co-Founder & Executive Director
Erez, a serial entrepreneur, devoted the last twenty years to building medical device start-up companies. Earlier in his career he built a strong technology background while leading inter-disciplinary projects for the Israel Air Force. He then went into medical imaging working on novel tissue characterization algorithms for intravascular ultrasound at Medinol. In 1999 Erez founded TopSpin Medical together with Eyal Kolka, which he then led as CEO for eight years. TopSpin developed a revolutionary miniaturized MRI catheter for diagnosing coronary plaque composition. The company successfully completed clinical trials in the US and Europe, commercialized the product and went public on the Tel-Aviv Stock Exchange in 2005. In 2008-2010 Erez co-founded two new companies with Eyal Kolka: Pi-Cardia developing non-implant based therapy for aortic stenosis and Clear-Cut.
Erez holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem.
Boaz Dovrin
VP of R&D & OPS
Boaz joined ClearCut after leading programs of Multidisciplinary products for more than 30 years and Medical Device programs for more than 13 years.
Earlier in his career, Boaz developed strong technology capabilities while leading inter-disciplinary projects for Israel Intelligence corps.
He then went into the defense industry for 11 years, leading development of defense products for Elbit Systems Ltd.
In 2007 he moved to lead programs in medical devices: CT and PET-CT for Philips Healthcare and Esthetic products using Ultrasound and Laser for Lumenis.
Boaz holds B.Sc. Aeronautics and Space Engineering in Technion, Israel. MBA from Bar-Ilan University, Israel.
Dr. Barry Rosen
Chief Medical Officer
Dr. Rosen is a breast surgical oncologist in the northwest suburbs of Chicago, where he has been in practice for over 25 years.
Dr. Rosen’s administrative positions have included Chief Medical Officer, Advocate Healthcare, and Eton Pharmaceuticals.
Dr. Rosen is the former chairman of NQMBC (National Quality Metrics for Breast Centers) and participates on the Patient Safety and Quality Committee for the American Society of Breast Surgeons.
He is a partner of Targeted Medical Education (TME), a group of national breast cancer leaders who collaborate with industry to promote physician education and research.
Locally, he is the medical director for the Breast Centers at Advocate Good Shepherd Hospital and AMITA/Alexian Brothers Medical Center.
Dr. Saul Stokar
Chief Scientist
Saul joined ClearCut after 30 years’ experience in medical devices, and specifically in MRI including at Elscint, GE and Aspect Imaging.
Saul is the author of numerous scientific articles and patents and holds a PhD in physics from Rockefeller University.
Boaz Dovrin
VP of R&D and OPS
Boaz joined ClearCut after leading programs of Multidisciplinary products for more than 30 years and Medical Device programs for more than 13 years.
Earlier in his career, Boaz developed strong technology capabilities while leading inter-disciplinary projects for Israel Intelligence corps.
He then went into the defense industry for 11 years, leading development of defense products for Elbit Systems Ltd.
In 2007 he moved to lead programs in medical devices: CT and PET-CT for Philips Healthcare and Esthetic products using Ultrasound and Laser for Lumenis.
Boaz holds B.Sc. Aeronautics and Space Engineering in Technion, Israel. MBA from Bar-Ilan University, Israel.
Dr. Barry Rosen
Chief Medical Officer
Dr. Rosen is a breast surgical oncologist in the northwest suburbs of Chicago, where he has been in practice for over 25 years.
Dr. Rosen’s administrative positions have included Chief Medical Officer, Advocate Healthcare, and Eton Pharmaceuticals.
Dr. Rosen is the former chairman of NQMBC (National Quality Metrics for Breast Centers) and participates on the Patient Safety and Quality Committee for the American Society of Breast Surgeons.
He is a partner of Targeted Medical Education (TME), a group of national breast cancer leaders who collaborate with industry to promote physician education and research.
Locally, he is the medical director for the Breast Centers at Advocate Good Shepherd Hospital and AMITA/Alexian Brothers Medical Center.
Prof. Moshe Papa
Member of the Scientific Advisory Board
Prof. Papa completed his medical studies at Tel Aviv medical school cum laude and underwent surgical training in 1983 at the Mount Sinai hospital in NY, where he spent 2 years as a surgical staff fellow at the National Cancer Institute NIH. In 1992 he returned to Israel as a staff member at the department of surgical oncology at Sheba medical center Tel Aviv Univ.
In 1999 Prof. Papa was appointed as the head of the Surgical Oncology division and founded the “Meirav”
Comprehensive Breast Center at Sheba and in 2001 he became the head of the department of General Surgery and surgical oncology as well as the head of Laboratory for Genetic Applications in Surgery. Prof. Papa has been involved in many Israeli and international innovative projects, including the company’s ClearCoast™ MRI System for margin assessment in breast conserving surgeries.
Dr. Saul Stokar
Chief Scientist
Saul joined ClearCut after 30 years’ experience in medical devices, and specifically in MRI including at Elscint, GE and Aspect Imaging.
Saul is the author of numerous scientific articles and patents and holds a PhD in physics from Rockefeller University.
Zachi Peles
Director of R&D
dalit heinsdorf melamed
QA Manager
Dalit brings over 15 years’ experience in medical device industry managing Quality Assurance, Quality Control and Regulatory Affairs of medical devices, mainly IVDs.
Dalit holds a B.Sc in Chemistry from TAU and ME in Polymer Engineering form the Technion.
Yael Merari
VP HR
Anna Levin
Director of Clinical Affairs
Zachi Peles
Director of R&D
Matan Saydoff
Software Manager
Shahar Garber
NPI & OPS Engineer
Dor Sobel
R&D Engineer
Samantha Natanzon
Clinical Manager
7 years experience in medical device companies. Specializing in clinical research, and managing clinical trial sites across Israel, Europe, and the UK.
BSc. in Biomedical Engineering from Afeka College of Engineering, Israel.
Chen Ratson
Finance & Business Dev. Manager
Roy Barak
H/W manager
Roy brings over 15 years of experience in hardware development, project management, and innovation within the technology and medical device industries. He has led end-to-end development services for numerous companies, specializing in medical engineering. Roy holds a B.Sc. in Electronics Engineering and an ME in Biomedical Engineering.
Dan avizemer
Product Manager
Chen Ratson
Finance & Business Dev. Manager
Tami Sharvit
Controller
Maya Nami
HR Business Partner
Liran Shmuel
Office Manager
Nitzan Sharon
Administrative Associate
Dor Sobel
R&D Engineer
Over 7 years in the medical device industry as a R&D engineer.
Experience in mechanical development, failure analysis of multidisciplinary products and user experience in hospital environments.
Participate in all product life cycle from design to post-market. B.Sc in Medical Engineering from Afeka, Israel.
Over 7 years in the medical device industry as a R&D engineer.
Experience in mechanical development, failure analysis of multidisciplinary products and user experience in hospital environments.
Participate in all product life cycle from design to post-market. B.Sc in Medical Engineering from Afeka, Israel.
Yael Merari
HR Consultant
Matan Saydoff
SW Consultant
Tami Sharvit
Controller
Over 7 years in the medical device industry as a R&D engineer.
Experience in mechanical development, failure analysis of multidisciplinary products and user experience in hospital environments.
Participate in all product life cycle from design to post-market. B.Sc in Medical Engineering from Afeka, Israel.
Liran Shmuel
Office Manager
Nitzan Sharon
Administrative Associate
Eden korbashi
R&D engineer
Over 3 years of expertise in medical device R&D and systems integration.
Specializes in cross-functional project coordination and the Design Transfer Process.
Experienced in production optimization and implementing innovative solutions.
B.Sc. in Medical Engineering, Afeka College of Engineering, Israel.
Over 7 years in the medical device industry as a R&D engineer.
Experience in mechanical development, failure analysis of multidisciplinary products and user experience in hospital environments.
Participate in all product life cycle from design to post-market. B.Sc in Medical Engineering from Afeka, Israel.
Tal elmalich
R&D engineer
Experienced in Software QA Automation and Manual testing, ISTQB, MCSE certified. Working in R&D team and responsible for implementing quality assurance and testing to ensure that company software meets the standards and requirements. Master of Business Administration – MBA focused in Organizational Behavior Studies from Peres Academic Center.
Eden Korbash
R&D engineer
Dalit Heinsdorf Melamed
QA Manager
Michael Pekar
Testing Engineer
Experienced in Software QA Automation and Manual testing, ISTQB, MCSE certified. Working in R&D team and responsible for implementing quality assurance and testing to ensure that company software meets the standards and requirements. Master of Business Administration – MBA focused in Organizational Behavior Studies from Peres Academic Center.
Tal Elmalic
Board Members
Michael Berman
Chairman
Michael is an entrepreneur and investor working with a select group of high potential development and early commercial stage companies.
He currently serves on the boards of 11 medical companies.
From 1995-2000 Mr. Berman was President of Boston Scientific/Scimed.
From 1997 to 2000 he was a member of Boston Scientific’s Executive Committee.
In 2010 Mr. Berman was inducted into the Minnesota Business Hall of Fame.
He earned a BS and MBA from Cornell University.
Dan Baruchi
Director
Hezi Himelfarb
CEO
Michael Berman
Chairman
Michael is an entrepreneur and investor working with a select group of high potential development and early commercial stage companies.
He currently serves on the boards of 11 medical companies.
From 1995-2000 Mr. Berman was President of Boston Scientific/Scimed.
From 1997 to 2000 he was a member of Boston Scientific’s Executive Committee.
In 2010 Mr. Berman was inducted into the Minnesota Business Hall of Fame.
He earned a BS and MBA from Cornell University.
Dan Baruchi
Director
Benny Sidon
Observer
Elsie M Fletcher
Observer
Elsie M Fletcher, CFA is a C-suite global financial services leader with expertise in investment management, corporate treasury and fintech.
She served as the Chief Investment Officer for two Fortune 500 corporate pension plans (Bank of America and Electronic Data Systems) and a major private bank.
Elsie most recently served as a Director at Tukman Grossman Capital Management. She is qualified as a Financial Expert with deep career experience as a Fiduciary.
Elsie holds a MBA in Finance degree from the University of North Texas and a BS degree in Medical Technology and Biochemistry from Louisiana State University.
Earlier in her career, Elsie managed a Clinical Immunology Laboratory in a cancer research hospital.
She lives in San Francisco, CA.
Aurel Schoeller
Observer
Eyal Kolka
Founder & Executive Director
Eyal, a serial entrepreneur, has devoted the last twenty years to building medical device start-up companies. He started his career as a physicist for the Israeli Defense Forces. He then went into investment banking joining Sigma P.C.M. Capital Markets as a partner. There he played a lead role in developing its assets management and investment banking activities. In 1999 Eyal joined Erez Golan and together they found TopSpin Medical. Eyal served as CFO and Senior VP of Business Development. TopSpin developed a revolutionary miniaturized MRI catheter for diagnosing coronary plaque composition. The company successfully completed clinical trials in the US and Europe, commercialized the product and went public on the Tel-Aviv Stock Exchange in 2005. In 2008 and 2010 Eyal co-founded two new companies with Erez Golan; Pi-Cardia developing non-implant based therapy for aortic stenosis and Clear-Cut.
Eyal holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem and an MBA from the Tel Aviv University
Erez Golan
Co-Founder & Executive Director
Erez, a serial entrepreneur, devoted the last twenty years to building medical device start-up companies. Earlier in his career he built a strong technology background while leading inter-disciplinary projects for the Israel Air Force. He then went into medical imaging working on novel tissue characterization algorithms for intravascular ultrasound at Medinol. In 1999 Erez founded TopSpin Medical together with Eyal Kolka, which he then led as CEO for eight years. TopSpin developed a revolutionary miniaturized MRI catheter for diagnosing coronary plaque composition. The company successfully completed clinical trials in the US and Europe, commercialized the product and went public on the Tel-Aviv Stock Exchange in 2005. In 2008-2010 Erez co-founded two new companies with Eyal Kolka: Pi-Cardia developing non-implant based therapy for aortic stenosis and Clear-Cut.
Erez holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem.
Bar Elmaliach
Director
Bar Elmaleh is an investor, partner and co-founder in several Israeli Venture capital funds such as Gefen BioMed, SIBF and HODL Capital. He serves as an active Director in Novaremed Pharma and ClearCut Medical since 2024.
Bar holds BA in Business Administration and Entrepreneurship from Reichman University and acts as a member of the Capital Market Club in Reichman University since 202
Eyal Kolka
Founder & Executive Director
Eyal, a serial entrepreneur, has devoted the last twenty years to building medical device start-up companies. He started his career as a physicist for the Israeli Defense Forces. He then went into investment banking joining Sigma P.C.M. Capital Markets as a partner. There he played a lead role in developing its assets management and investment banking activities. In 1999 Eyal joined Erez Golan and together they found TopSpin Medical. Eyal served as CFO and Senior VP of Business Development. TopSpin developed a revolutionary miniaturized MRI catheter for diagnosing coronary plaque composition. The company successfully completed clinical trials in the US and Europe, commercialized the product and went public on the Tel-Aviv Stock Exchange in 2005. In 2008 and 2010 Eyal co-founded two new companies with Erez Golan; Pi-Cardia developing non-implant based therapy for aortic stenosis and Clear-Cut.
Eyal holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem and an MBA from the Tel Aviv University
Erez Golan
Co-Founder & Executive Director
Erez, a serial entrepreneur, devoted the last twenty years to building medical device start-up companies. Earlier in his career he built a strong technology background while leading inter-disciplinary projects for the Israel Air Force. He then went into medical imaging working on novel tissue characterization algorithms for intravascular ultrasound at Medinol. In 1999 Erez founded TopSpin Medical together with Eyal Kolka, which he then led as CEO for eight years. TopSpin developed a revolutionary miniaturized MRI catheter for diagnosing coronary plaque composition. The company successfully completed clinical trials in the US and Europe, commercialized the product and went public on the Tel-Aviv Stock Exchange in 2005. In 2008-2010 Erez co-founded two new companies with Eyal Kolka: Pi-Cardia developing non-implant based therapy for aortic stenosis and Clear-Cut.
Erez holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem.
Aurel Schoeller
Observer
Elsie M Fletcher
Observer
Elsie M Fletcher, CFA is a C-suite global financial services leader with expertise in investment management, corporate treasury and fintech.
She served as the Chief Investment Officer for two Fortune 500 corporate pension plans (Bank of America and Electronic Data Systems) and a major private bank.
Elsie most recently served as a Director at Tukman Grossman Capital Management. She is qualified as a Financial Expert with deep career experience as a Fiduciary.
Elsie holds a MBA in Finance degree from the University of North Texas and a BS degree in Medical Technology and Biochemistry from Louisiana State University.
Earlier in her career, Elsie managed a Clinical Immunology Laboratory in a cancer research hospital.
She lives in San Francisco, CA.